Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
U.S. Senator Elizabeth Warren has sent a letter to the nation's leading patent attorney asking for further review of Merck's new patent application for its cancer drug Keytruda, which seeks to block the drug. , he said.
Read Full NewsMichael Wechsler, MD, reports 59% of patients in clinical remission with twice-yearly depemokimab at year 1 maintained it at year 2 in SWIFT/AGILE.
Experts Discuss PAH Treatment Selection and Access
HCPLive Five at CHEST 2026
Kim Henriksen, PhD, discusses research evaluating blood-based biomarkers of blood-brain barrier remodeling and immune cell activity in multiple sclerosis, including their potential to track treatment responses and inform future biomarker development.
Brian Snelling, MD, director of the stroke program at Marcus Neuroscience Institute discussed delays in calling 911 after stroke onset, gaps in awareness of atypical symptoms, and how to reach underserved populations.
The clinical professor of neurology and pediatrics at The Ohio State University Wexner Medical Center discussed payer step therapy, earlier preventive treatment, and questions the updated guideline leaves open.
Shadi Yaghi, MD, FAHA, Chair of Neurology at Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center, discusses a new calculator that predicts stroke risk within 30 days of a procedure.
1.
Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities
2.
Herpes virus-based vaccine shows promise in targeting tumors without side effects
3.
Even a few mutated cells can significantly impact how blood cancers develop, study finds
4.
Depression risk higher among long-term breast cancer survivors than women without breast cancer history
5.
CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma
1.
Cancer Prevention Through Early Immune Surveillance Enhancement
2.
Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment
3.
Contemporary Methods in Hematology Across Clinical Settings
4.
Public Health Through Cancer Survivorship Infrastructure at the Community Level
5.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
2.
The Role of Platelets in Normal Blood Clotting
3.
How Multidisciplinary Teams Support Modern Cancer Care
4.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge